Inborn Errors of Immunity on the Island of Ireland - a Cross-Jurisdictional UKPID/ESID Registry Report
© 2022. The Author(s)..
The epidemiology of inborn errors of immunity (IEI) in the Republic of Ireland was first published in 2005 but has not been updated since. IEI prevalence data from Northern Ireland was last published in 2018. Using data from the United Kingdom Primary Immune Deficiency (UKPID) and European Society for Immunodeficiencies (ESID) registries, we reviewed all registered cases of IEI affecting adult patients ≥ 18 years of age from the two largest immunology specialist centres in Northern Ireland and the Republic of Ireland, respectively and calculated the combined minimum adult prevalence of IEI on the island of Ireland for the first time. We also recorded data pertaining to presenting symptoms of IEI, diagnostic delay, immunoglobulin data, and genetic testing, as well as briefly reporting data pertaining to secondary immunodeficiency in both countries. As of 1 May 2020, we identified a minimum adult IEI prevalence in Ireland of 8.85/100,000 population.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:42 |
|---|---|
| Enthalten in: |
Journal of clinical immunology - 42(2022), 6 vom: 23. Aug., Seite 1293-1299 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ryan, Paul [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ESID |
|---|
| Anmerkungen: |
Date Completed 10.10.2022 Date Revised 19.10.2022 published: Print-Electronic ErratumIn: J Clin Immunol. 2022 Jun 22;:. - PMID 35731325 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s10875-022-01274-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341270121 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341270121 | ||
| 003 | DE-627 | ||
| 005 | 20231226011406.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s10875-022-01274-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1137.xml |
| 035 | |a (DE-627)NLM341270121 | ||
| 035 | |a (NLM)35604475 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ryan, Paul |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inborn Errors of Immunity on the Island of Ireland - a Cross-Jurisdictional UKPID/ESID Registry Report |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.10.2022 | ||
| 500 | |a Date Revised 19.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: J Clin Immunol. 2022 Jun 22;:. - PMID 35731325 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a The epidemiology of inborn errors of immunity (IEI) in the Republic of Ireland was first published in 2005 but has not been updated since. IEI prevalence data from Northern Ireland was last published in 2018. Using data from the United Kingdom Primary Immune Deficiency (UKPID) and European Society for Immunodeficiencies (ESID) registries, we reviewed all registered cases of IEI affecting adult patients ≥ 18 years of age from the two largest immunology specialist centres in Northern Ireland and the Republic of Ireland, respectively and calculated the combined minimum adult prevalence of IEI on the island of Ireland for the first time. We also recorded data pertaining to presenting symptoms of IEI, diagnostic delay, immunoglobulin data, and genetic testing, as well as briefly reporting data pertaining to secondary immunodeficiency in both countries. As of 1 May 2020, we identified a minimum adult IEI prevalence in Ireland of 8.85/100,000 population | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ESID | |
| 650 | 4 | |a IEI (inborn errors of immunity) | |
| 650 | 4 | |a Immunodeficiency | |
| 650 | 4 | |a UKPID | |
| 650 | 4 | |a prevalence | |
| 650 | 4 | |a registry | |
| 650 | 7 | |a Immunoglobulins |2 NLM | |
| 700 | 1 | |a Redenbaugh, Vyanka |e verfasserin |4 aut | |
| 700 | 1 | |a McGucken, Jayne |e verfasserin |4 aut | |
| 700 | 1 | |a Kindle, Gerhard |e verfasserin |4 aut | |
| 700 | 1 | |a Devlin, Lisa A |e verfasserin |4 aut | |
| 700 | 1 | |a Coulter, Tanya |e verfasserin |4 aut | |
| 700 | 1 | |a Buckland, Matthew S |e verfasserin |4 aut | |
| 700 | 1 | |a Seppänen, Mikko R J |e verfasserin |4 aut | |
| 700 | 1 | |a Conlon, Niall P |e verfasserin |4 aut | |
| 700 | 1 | |a Feighery, Conleth |e verfasserin |4 aut | |
| 700 | 1 | |a Edgar, J David M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical immunology |d 1981 |g 42(2022), 6 vom: 23. Aug., Seite 1293-1299 |w (DE-627)NLM012677426 |x 1573-2592 |7 nnns |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:6 |g day:23 |g month:08 |g pages:1293-1299 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10875-022-01274-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 42 |j 2022 |e 6 |b 23 |c 08 |h 1293-1299 | ||